Checkmate Pharmaceuticals
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Checkmate Pharmaceuticals's balance sheet done over the years? Its assets were worth $78,838,000 last year, which is less than in the previous period. 12% of Checkmate Pharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $9,379,000, which means an increase by 19% compared compared to last year.
Debt to Assets
| 2018 | 12494000 | 3.32M | 26.59% |
|---|---|---|---|
| 2019 | 5126000 | 5.63M | 109.91% |
| 2020 | 133074000 | 7.87M | 5.92% |
| 2021 | 78838000 | 9.37M | 11.9% |
CMPI Balance Sheet (2018 – 2021)
| 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|
Assets | ||||
Current assets: | ||||
Cash and cash equivalents | 50.67M | 43.05M | 4.18M | 12.05M |
Short term investments | 0 | 51.83M | 0 | 0 |
Net receivables | 0 | 0 | 0 | 0 |
Inventory | 0 | 0 | 0 | 0 |
Other current assets | 23.28M | 7.21M | 941K | 435K |
Total current assets | 73.96M | 102.10M | 5.12M | 12.49M |
Non-current assets: | ||||
Property, Plant and Equipment | 0 | 0 | 0 | 0 |
Goodwill | 0 | 0 | 0 | 0 |
Intangible assets | 0 | 0 | 0 | 0 |
Long term investments | 0 | 30.97M | 0 | 0 |
Other non-current assets | 4.87M | 0 | 0 | 0 |
Total non-current assets | 4.87M | 30.97M | 0 | 0 |
Total assets | 78.83M | 133.07M | 5.12M | 12.49M |
Liabilities | ||||
| Current liabilities: | ||||
Accounts payable | ||||
Deferred revenue | 0 | 0 | 0 | 0 |
Short term debt | 0 | 0 | 0 | 0 |
Total current liabilities | 9.37M | 7.87M | 5.63M | 3.32M |
| Non-current liabilities: | ||||
Long term debt | 0 | 0 | 0 | 0 |
Deferred tax | 0 | 0 | 0 | 0 |
Other non-current liabilities | 3.38M | 0 | 0 | 0 |
Total non-current liabilities | 3.38M | 0 | 0 | 0 |
Total liabilities | 9.37M | 7.87M | 5.63M | 3.32M |
| Data source | Data source |